Modifying matrix remodeling to prevent heart failure

K. Y. Deleon, A. Yabluchanskiy, M. D. Winniford, R. A. Lange, R. J. Chilton, M. L. Lindsey

Producción científica: Chapter

1 Cita (Scopus)


In the USA, cardiovascular disease is the leading cause of morbidity and mortality, accounting for approximately 40% of all deaths. Myocardial infarction or its sequelae is the primary cause of cardiovascular disease death. Despite advances in novel therapeutic strategies over the past 30 years, heart failure morbidity and mortality remain high for the post-myocardial infarction patient. Extracellular matrix remodeling and its role in heart failure are explored in this chapter: the key players involved, current therapeutic options and future trends are discussed.

Idioma originalEnglish (US)
Título de la publicación alojadaPathology and Therapies
EditorialElsevier Ltd
Número de páginas20
ISBN (versión impresa)9780857096586
EstadoPublished - feb 2014

ASJC Scopus subject areas

  • General Dentistry
  • General Medicine


Profundice en los temas de investigación de 'Modifying matrix remodeling to prevent heart failure'. En conjunto forman una huella única.

Citar esto